BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, February 22, 2026
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

Vascutek graft system enables minimally invasive AAA repair

June 29, 2009
By Lynn Yoffee
For many years, the standard treatment for infrarenal abdominal aortic aneurisms (AAA) has been open surgery. An investigational stent system from Vascutek (Glasgow, Scotland) will enable a minimally invasive treatment. (Medical Device Daily)
Read More

Exosome, DxS collaborating on blood-based cancer tests

June 25, 2009
By Lynn Yoffee

Old technique may yield quick test for early Alzheimer's

June 25, 2009
By Lynn Yoffee
New research out of Canada shows that near-infrared biospectroscopy – a scientific technique around for decades – may provide early diagnosis of Alzheimer's disease and other neurodegenerative disorders. (Diagnostics & Imaging Week)
Read More

Old technique may yield quick test for early Alzheimer's

June 23, 2009
By Lynn Yoffee
New research out of Canada shows that near-infrared biospectroscopy – a scientific technique around for decades – may provide early diagnosis of Alzheimer's disease and other neurodegenerative disorders. (Medical Device Daily)
Read More

Healthcare costs to rise 9% in 2010, outpacing inflation

June 22, 2009
By Lynn Yoffee
Medical device makers take heed: If you're developing expensive technologies that have more "wow" factor than "value-add" to the healthcare system, you might want to start reworking your company's mission- or risk faltering. (Medical Device Daily)
Read More

AHA extends tPA treatment window for stroke patients

June 18, 2009
By Lynn Yoffee

EyeIC's glaucoma diagnostic software wins FDA clearance

June 18, 2009
By Lynn Yoffee

EyeIC's glaucoma diagnostic software wins FDA clearance

June 15, 2009
By Lynn Yoffee

WHO declares H1N1 pandemic, enacts highest alert level

June 12, 2009
By Lynn Yoffee
As the number of infections and deaths continue to rise – and for the first time in four decades – the World Health Organization (Geneva, Switzerland) has declared a pandemic influenza outbreak of an entirely new virus: swine (H1N1) influenza. (Medical Device Daily)
Read More

WHO Declares H1N1 Pandemic, Enacts Highest Alert Level

June 12, 2009
By Lynn Yoffee
Previous 1 2 … 17 18 19 20 21 22 23 24 25 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing